Most PET studies of the serotonin 1A receptor in MDD used the receptor antagonist radioligand, [carbonyl-<sup>11</sup>C]WAY100635; however the interpretation of the combined results has been contentious owing to reports of higher or lower binding in MDD with different outcome measures. The gene discussed is HTR1A; the disease is major depressive disorder.